Page last updated: 2024-09-03

bruceine d and Ovarian Neoplasms

bruceine d has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Feng, R; Han, M; Hu, Y; Wang, L; Yang, Y; Zhu, J	1

Other Studies

1 other study(ies) available for bruceine d and Ovarian Neoplasms

Article	Year
Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2023, Volume: 71, Issue:5 Topics: Afatinib; Cell Line, Tumor; Cell Proliferation; DNA Damage; ErbB Receptors; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms	2023

Article

Year

Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2023, Volume: 71, Issue:5

Topics: Afatinib; Cell Line, Tumor; Cell Proliferation; DNA Damage; ErbB Receptors; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms

2023